# FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)

> **NCT03489993** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 8 (actual)

## Conditions studied

- Hypophosphatemia
- X-linked Hypophosphatemia
- Renin-angiotensin System
- Left Ventricular Hypertrophy

## Interventions

- **DIAGNOSTIC_TEST:** Ang II and Ang-(1-7)
- **DIAGNOSTIC_TEST:** FGF23 and klotho

## Key facts

- **NCT ID:** NCT03489993
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-06
- **Primary completion:** 2020-12-23
- **Final completion:** 2020-12-23
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03489993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03489993, "FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03489993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*